| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 0.004 |